South Korea Expands Active Pharmaceutical Ingredient Development
South Korea Expands Active Pharmaceutical Ingredient Development
Attachment: Korea API Projects
KOFU, JAPAN--May 24, 2021--Researched by Industrial Info Resources (Sugar Land, Texas)--In South Korea, the expansion of production facilities for active pharmaceutical ingredients (APIs) is growing steadily and seems to be focusing on grassroot projects and expansions, as exports of APIs needed to produce final products such as COVID-19 vaccines increase.
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- Samsung Biologics Constructing ADC Plant in South Korea
- Data Center Activity Propels Virginia to $12.7 Billion of Projects Under Co...
- Pharma Company Zoetis Signs PPA with Scout Clean Energy to Support Growing ...
- China's Rongsheng Petrochemical Ups Role in Polyester Chips
- Suffolk Construction Has Hand in $1.9 Billion Worth of Projects